Identification of RNA biomarkers in autism

Identification of RNA biomarkers in autism

Project details

Autism is a complex, heterogeneous neurodevelopmental disability with an early childhood onset and a lifelong course. The identification of biomarkers to define biologically homogeneous subgroups, predict risk, and aid the diagnosis of autism would greatly facilitate the management of this common disorder, which affects about 1 per cent of the population.

This research project seeks to identify circulating RNA biomarkers that are dysregulated in autism and, using this information, aims to develop a diagnostic blood test for autism. In this way, the research seeks to overcome the current difficulties that exist around obtaining a diagnosis of autism and, by doing so, should help to facilitate intervention and thus improve outcomes for autistic children and their families. Students will develop skills in RNA biology, next generation sequencing, and bioinformatics.

About our research group

Dr Ken Pang is a paediatrician, who currently holds joint positions at the Walter and Eliza Hall Institute, the Murdoch Children’s Research Institute, and the Royal Children’s Hospital.

His research team studies the role of extracellular RNAs in the pathogenesis, diagnosis and treatment of disease.

Researchers:

Dr Ken Pang

Ken
Dr
Ken
Pang
Senior Postdoctoral Fellow

Project Type: